Sona Nanotech Inc (TSE:SONA) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Sona Nanotech Inc. has successfully completed a private placement, raising $1.643 million in gross proceeds, which will fund the advancement of a novel cancer therapy and general corporate purposes. The company’s innovative Targeted Hyperthermia Therapy, using heat to combat tumors, is expected to undergo a first-in-human clinical trial. Despite the related-party transactions involved, the financing adheres to regulatory exemptions, ensuring minority shareholder protection.
For further insights into TSE:SONA stock, check out TipRanks’ Stock Analysis page.
